Evidence map›Paper›PMID 24739582›Full record

ReviewNature reviews. Cancer2014

Turning ecology and evolution against cancer.

Kirill S Korolev, Joao B Xavier, Jeff Gore

Abstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 133 papers.

0numbers the graph read from it
0cells of the map it votes in
133citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

133 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. The theory of tumor immuno-ecodynamics.Frontiers in immunology · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Range expansions across landscapes with quenched noise.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  14. Article
  15. Article
  16. Modeling tumors as species-rich ecological communities.bioRxiv : the preprint server for biology · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article

73 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kirill S KorolevBioinformatics Program, Boston University, 44 Cummington Mall, Boston, Massachusetts 02215, USA.
Joao B XavierMemorial Sloan-Kettering Cancer Center, Computational Biology Program, New York, New York, USA.
Jeff GoreMassachusetts Institute of Technology, 400 Technology Square, NE46-609 Cambridge, Massachusetts, USA.

Funding

Variability of Cellular Responses to Growth Factors and Drugs During TumorgenesisU54CA148967 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI SANDER, CHRIS · 2010 to 2014
$13.8M
Engineering microbial social interactions: Towards new anti-biofilm therapiesDP2OD008440 · OD · SLOAN-KETTERING INST CAN RESEARCH · PI XAVIER, JOAO · 2011 to 2015
$2.9M
Early warning indicators of tipping points in biological systemsDP2AG044279 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GORE, JEFF · 2012 to 2012
$2.3M
NCI NIH HHS CA148967NIA NIH HHS DP2 AG044279NIH HHS DP2OD008440
6 · The paper itself

Abstract

The fight against cancer has drawn researchers from a wide variety of disciplines, ranging from molecular biology to physics, but the perspective of an ecological theorist has been mostly overlooked. By thinking about the cells that make up a tumour as an endangered species, cancer vulnerabilities become more apparent. Studies in conservation biology and microbial experiments indicate that extinction is a complex phenomenon, which is often driven by the interaction of ecological and evolutionary processes. Recent advances in cancer research have shown that tumours, like species striving for survival, harbour intricate population dynamics, which suggests the possibility to exploit the ecology of tumours for treatment.

Indexed as

EcologyModels, TheoreticalAnimalsCell LineageCell ProliferationDisease ProgressionEcosystemEvolution, MolecularGenetic VariationHumansNeoplasmsRemission Induction

Identifiers

PMID24739582
PMCPMC13213539

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.